本页面由Tiger Trade Technology Pte. Ltd.提供服务

Taysha Gene Therapies, Inc.

4.14
-0.3500-7.80%
盘后:4.140.00000.00%19:30 EDT
成交量:421.42万
成交额:1,783.06万
市值:13.49亿
市盈率:-10.03
高:4.56
开:4.46
低:4.13
收:4.49
52周最高:7.30
52周最低:3.69
股本:3.26亿
流通股本:2.33亿
量比:0.92
换手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-0.4126
每股收益(LYR):-0.3409
净资产收益率:-47.05%
总资产收益率:-23.82%
市净率:3.48
市盈率(LYR):-12.14

数据加载中...

2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

重要事件披露

Form 8-K - Current report
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/09

重要事件披露

Form 8-K - Current report
2025/10/02

重要事件披露

Form 8-K - Current report
2025/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities